PDF version: Statement 26 June 2014 (PDF 255 KB)
We refer to page 35 of the MSAC Public Summary Document.
As at 19 June 2014, the Department of Health is of the opinion the digene HPV Hybrid Capture 2 test and the digene HPV Genotyping PS test when used in combination, and the BD Onclarity HPV Assay and Control Set test, meet the recommended criteria set out at page 35 of the MSAC Public Summary document and those tests together with the Roche cobas® 4800 and the Abbott Real Time PCR tests meet the criteria. Other tests may meet the recommended criteria. It is not the function of MSAC to consider these or other HPV tests against these recommended criteria in the Renewal of the National Cervical Screening Program. Decisions as to listings on the Medicare Benefits Schedule are made by the Commonwealth.